Search
Xanthinol
go.drugbank.com/drugs/DB09092ApprovedWithdrawn[L1080] It was approved as a drug in 1998 in Canada and nowadays its status is cancelled post marketing. … Xanthinol is a very potent water-soluble derivative of niacin that can be found in diet supplements. It is also known as xanthinol nicotinate.
Glyphosate
go.drugbank.com/drugs/DB04539ExperimentalCategories: Compounds used in a research, industrial, or household settingAllosamidin
go.drugbank.com/drugs/DB04628ExperimentalAllosamidin exhibits extremely potent inhibitory activity against chitinases from a number of sources, particularly from <i>Candida albicans</i>, and can be utilized as potent antifungal agent.
Categories: Compounds used in a research, industrial, or household settingMotuporin
go.drugbank.com/drugs/DB04738ExperimentalMotuporin is a toxin isolated from the marine sponge Thenonella swinhoie grey.
Tagetitoxin
go.drugbank.com/drugs/DB04788ExperimentalTagetitoxin is a bacterial phytotoxin. It preferentially inhibits eukaryotic RNA polymerase.
Bifonazole
go.drugbank.com/drugs/DB04794ApprovedBifonazole is an azole antifungal drug.
Products: MYCOSPOR POLVO AL 1%, BIFONAZOL CREMA AL 1%Thenoyltrifluoroacetone
go.drugbank.com/drugs/DB04795ExperimentalThenoyltrifluoroacetone is a chelating agent and inhibitor of cellular respiration.
Categories: Compounds used in a research, industrial, or household settingBuformin
go.drugbank.com/drugs/DB04830ApprovedWithdrawnIt was withdrawn from the market in most countries due to a high risk of causing lactic acidosis.
Fluspirilene
go.drugbank.com/drugs/DB04842ApprovedWithdrawnA long-acting injectable antipsychotic agent used for chronic schizophrenia.
Posizolid
go.drugbank.com/drugs/DB04850InvestigationalPosizolid (AZD2563) is an oxazolidinone antibiotic. In July 2002, after completion of phase I trials in December 2001, AstraZeneca announced that they were no longer pursuing the development of Posizolid, presumably due to negative trial...